T2 Biosystems, Inc. Lease, Cost
T2 Biosystems, Inc. reported Lease, Cost of $3.35 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2024-04-01
- T2 Biosystems, Inc. lease, cost for the quarter ending 2019-12-31 was $674.00K.
- T2 Biosystems, Inc. lease, cost for the quarter ending 2019-09-30 was $662.00K.
- T2 Biosystems, Inc. lease, cost for the quarter ending 2019-06-30 was $774.00K.
- T2 Biosystems, Inc. lease, cost for the quarter ending 2019-03-31 was $814.00K.
- T2 Biosystems, Inc. lease, cost for fiscal 2023 was $3.35M, a 1.15% increase from fiscal 2022.
- T2 Biosystems, Inc. lease, cost for fiscal 2022 was $3.32M, a 7.03% increase from fiscal 2021.
- T2 Biosystems, Inc. lease, cost for fiscal 2021 was $3.10M, a 14.82% increase from fiscal 2020.
- T2 Biosystems, Inc. lease, cost for fiscal 2020 was $2.70M, a 7.73% decline from fiscal 2019.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-12-31 | $3.35M 10-K · filed 2024-04-01 | |||
| 2022-12-31 | $3.32M 10-K · filed 2024-04-01 | |||
| 2021-12-31 | $3.10M 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $2.70M 10-K · filed 2022-03-23 | |||
| 2019-12-31 | $674.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $1.34M derived: sum of 2 quarters · filed 2021-03-31 | $2.11M derived: sum of 3 quarters · filed 2021-03-31 | $2.92M 10-K · filed 2021-03-31 |
| 2019-09-30 | $662.00K 10-Q · filed 2019-11-18 | $1.44M derived: sum of 2 quarters · filed 2019-11-18 | $2.25M 10-Q · filed 2019-11-18 | |
| 2019-06-30 | $774.00K 10-Q · filed 2019-08-02 | $1.59M 10-Q · filed 2019-08-02 | ||
| 2019-03-31 | $814.00K 10-Q · filed 2019-05-10 |